Navigation Links
GSI to Present at Upcoming Investor Growth Conferences
Date:1/9/2008

BILLERICA, Mass., Jan. 9 /PRNewswire-FirstCall/ -- GSI Group Inc. (Nasdaq: GSIG), a leading manufacturer of laser-based precision motion products and systems, today announced it will be presenting at both the Needham & Company 10th Annual Growth Conference in New York City on January 10th and the Fifth Annual Sidoti & Company Emerging Growth Conference in Palm Beach Florida on January 22nd.

Mr. Robert Bowen, Chief Financial Officer, will be speaking at both events.

About GSI Group Inc.

GSI Group Inc. supplies laser-based precision motion products and systems to the global medical, semiconductor, electronics, and industrial markets. GSI Group Inc.'s common shares are listed on the NASDAQ exchange under the symbol GSIG.

Certain statements in this news release may constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the United States Securities Act of 1933 and Section 21E of the United States Securities Exchange Act of 1934. These forward-looking statements may relate to anticipated financial performance, management's plans and objectives for future operations, business prospects, outcome of regulatory proceedings, market conditions, tax issues and other matters. All statements contained in this news release that do not relate to matters of historical fact should be considered forward-looking statements, and are generally identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "objective" and other similar expressions. Readers should not place undue reliance on the forward- looking statements contained in this news release. Such statements are based on management's beliefs and assumptions and on information currently available to management and are subject to risks, uncertainties and changes in condition, significance, value and effect. Other risks include the fact that the Company's sales have been and are expected to continue to be dependent upon customer capital equipment expenditures, which are, in turn, affected by business cycles in the markets served by those customers. Other factors include volatility in the semiconductor industry, the risk of order delays and cancellations, the risk of delays by customers in introducing their new products and market acceptance of products incorporating subsystems supplied by the Company, risks of currency fluctuations, risks to the Company of delays in its new products, our ability to continue to reduce costs and capital expenditures, our ability to focus R&D investment and integrate acquisitions, changes in applicable accounting standards, tax regulations or other external regulatory rules and standards, and other risks detailed in reports and documents filed by the Company with the United States Securities and Exchange Commission and with securities regulatory authorities in Canada. Such risks, uncertainties and changes in condition, significance, value and effect, many of which are beyond the Company's control, could cause the Company's actual results and other future events to differ materially from those anticipated. The Company does not, however, assume any obligation to update these forward- looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. For more information contact: Investor Relations, 978-439-5511, Ray Ruddy, (ext. 6170)


'/>"/>
SOURCE GSI Group Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
2. Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference
3. Emageon to Present at the 26th Annual JPMorgan Healthcare Conference
4. Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
5. Covance to Present at 26th Annual JPMorgan Healthcare Conference
6. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
7. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
8. DaVita Inc. to Present at JPMorgan Healthcare Conference
9. Hologic to Present at the 26th Annual JP Morgan Healthcare Conference
10. WebMD to Present at Upcoming Investor Conferences
11. Neurochem to present at JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 18, 2017 , ... The CHP suggests that California drivers can avoid hydroplaning ... down and increasing the space between themselves and other vehicles, according to a January ... Raymond R. Hassanlou notes that, rain or shine, drivers should always incorporate safe driving ...
(Date:1/19/2017)... Norwalk, CT (PRWEB) , ... January 19, 2017 , ... ... Dr. Sang H. Kim, a highly experienced and compassionate dermatologist. Dr. Kim brings ... skincare center . , “It is with considerable pleasure to welcome back Dr. Kim ...
(Date:1/19/2017)... ... 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, ... Over the past 20 years SFI has been recognized as the world’s leader in ... clients into the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, ...
(Date:1/19/2017)... Seabrook, NH (PRWEB) , ... January 19, 2017 , ... ... develop its business plan and implement new sales and marketing strategies. Grover comes with ... spent the last 5 and a half years as Executive Vice President of Direct ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the American Osteopathic College of Proctology) announced today the opening of 3 ... California ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 The U.S. Food and ... Chronic Idiopathic Constipation (CIC) in adult patients. ... gastrointestinal disorders," said Julie Beitz , M.D., director of ... for Drug Evaluation and Research. "With the availability of new ... treatment for their condition." ...
(Date:1/19/2017)... 2017  Stealth BioTherapeutics Inc. ( Stealth ), a ... today announced new additions to its senior leadership team: ... Officer, and Daniel Geffken as interim Chief ... Carr , Pharm.D. has been promoted to Chief Clinical ... welcome Doug and Daniel to our management team, as ...
(Date:1/19/2017)... 2017 James Gilbart ... Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European Oncology ... an article by James Gilbart and ...
Breaking Medicine Technology: